A detailed history of Tobam transactions in Abb Vie Inc. stock. As of the latest transaction made, Tobam holds 67,967 shares of ABBV stock, worth $12 Million. This represents 2.45% of its overall portfolio holdings.

Number of Shares
67,967
Previous 92,627 26.62%
Holding current value
$12 Million
Previous $15.9 Million 15.52%
% of portfolio
2.45%
Previous 2.49%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 09, 2024

SELL
$163.84 - $199.33 $4.04 Million - $4.92 Million
-24,660 Reduced 26.62%
67,967 $13.4 Million
Q2 2024

Jul 29, 2024

SELL
$154.79 - $180.76 $12.8 Million - $15 Million
-82,734 Reduced 47.18%
92,627 $15.9 Million
Q1 2024

May 02, 2024

SELL
$159.82 - $182.1 $6.93 Million - $7.9 Million
-43,386 Reduced 19.83%
175,361 $31.9 Million
Q4 2023

Jan 26, 2024

SELL
$137.6 - $154.97 $3.7 Million - $4.17 Million
-26,904 Reduced 10.95%
218,747 $33.9 Million
Q3 2023

Oct 31, 2023

SELL
$133.59 - $154.65 $4.29 Million - $4.97 Million
-32,141 Reduced 11.57%
245,651 $36.6 Million
Q2 2023

Jul 31, 2023

BUY
$132.51 - $164.9 $7.55 Million - $9.4 Million
57,004 Added 25.82%
277,792 $37.4 Million
Q1 2023

May 03, 2023

BUY
$144.61 - $166.54 $7.21 Million - $8.31 Million
49,873 Added 29.18%
220,788 $35.2 Million
Q4 2022

Feb 02, 2023

BUY
$138.31 - $165.87 $6.98 Million - $8.37 Million
50,459 Added 41.89%
170,915 $27.6 Million
Q3 2022

Nov 02, 2022

BUY
$134.21 - $153.93 $9.68 Million - $11.1 Million
72,131 Added 149.26%
120,456 $16.2 Million
Q2 2022

Aug 02, 2022

BUY
$137.62 - $174.96 $5.46 Million - $6.94 Million
39,651 Added 457.12%
48,325 $7.4 Million
Q1 2022

Apr 25, 2022

BUY
$131.98 - $163.75 $378,518 - $469,635
2,868 Added 49.4%
8,674 $1.41 Million
Q2 2021

Aug 11, 2021

SELL
$105.21 - $117.21 $36,297 - $40,437
-345 Reduced 5.61%
5,806 $654,000
Q4 2020

Feb 03, 2021

BUY
$80.49 - $108.67 $8,129 - $10,975
101 Added 1.67%
6,151 $659,000
Q3 2020

Nov 12, 2020

BUY
$85.91 - $100.83 $519,755 - $610,021
6,050 New
6,050 $530,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $313B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Tobam Portfolio

Follow Tobam and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tobam, based on Form 13F filings with the SEC.

News

Stay updated on Tobam with notifications on news.